On November 15, 2016, the Federal Trade Commission (FTC) released a new Policy Statement on marketing claims for over the counter (OTC) homeopathic drugs. The Policy Statement is here and the press release and accompanying report are available here and here. The Policy Statement signals the end of the FTC’s decades-long approach of rarely challenging misleading claims for products that were or claimed to be homeopathic. Going forward, homeopathic OTC drugs, like all other OTC drugs, will have to support their claims with competent and reliable scientific evidence or risk an FTC enforcement action.
Article Source:
OFW Law